News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,023 Results
Type
Article (87969)
Company Profile (825)
Press Release (781212)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233264)
Career Advice (4147)
Deals (39880)
Drug Delivery (151)
Drug Development (91418)
Employer Resources (205)
FDA (18388)
Job Trends (17428)
News (397919)
Policy (39969)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (146)
Alliances (56981)
ALS (180)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (346)
Approvals (18568)
Artificial intelligence (624)
Autoimmune disease (159)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (661)
Cancer (5016)
Cardiovascular disease (442)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (824)
Cervical cancer (37)
Clinical research (77000)
Collaboration (1802)
Company closure (5)
Compensation (1150)
Complete response letters (70)
COVID-19 (2991)
CRISPR (99)
C-suite (856)
Cystic fibrosis (154)
Data (6237)
Decentralized trials (2)
Denatured (72)
Depression (150)
Diabetes (531)
Diagnostics (7222)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (301)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100120)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135053)
Executive appointments (1031)
FDA (21555)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1552)
Gene editing (215)
Generative AI (64)
Gene therapy (668)
GLP-1 (1121)
Government (5438)
Grass and pollen (8)
Guidances (385)
Healthcare (20944)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (290)
Immuno-oncology (58)
Indications (94)
Infectious disease (3277)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (244)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (67)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (15)
Lung cancer (676)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (844)
MASH (172)
Medical device (15022)
Medtech (15073)
Mergers & acquisitions (22981)
Metabolic disorders (1388)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (353)
Neuropsychiatric disorders (96)
Neuroscience (3102)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5111)
Now hiring (66)
Obesity (671)
Opinion (335)
Ovarian cancer (166)
Pain (206)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (503)
Patient recruitment (475)
Peanut (60)
People (66898)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23795)
Phase II (33412)
Phase III (25180)
Pipeline (4961)
Policy (334)
Postmarket research (3554)
Preclinical (10691)
Press Release (72)
Prostate cancer (243)
Psychedelics (53)
Radiopharmaceuticals (300)
Rare diseases (889)
Real estate (7439)
Recruiting (80)
Regulatory (28990)
Reports (67)
Research institute (2724)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (256)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (122)
Vaccines (1142)
Venture capital (95)
Weight loss (462)
Women's health (85)
Worklife (21)
Date
Today (211)
Last 7 days (456)
Last 30 days (2374)
Last 365 days (32994)
2026 (2332)
2025 (33231)
2024 (38141)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (51548)
Australia (9050)
California (11498)
Canada (3301)
China (1161)
Colorado (487)
Connecticut (499)
Delaware (344)
Europe (118424)
Florida (1680)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (960)
India (67)
Indiana (541)
Iowa (24)
Japan (426)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1453)
Massachusetts (8470)
Michigan (356)
Minnesota (663)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3094)
New Mexico (33)
New York (3039)
North Carolina (1606)
North Dakota (10)
Northern California (5491)
Ohio (352)
Oklahoma (22)
Oregon (54)
Pennsylvania (2300)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4440)
Tennessee (176)
Texas (1813)
United States (41496)
Utah (344)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (970)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 870,023 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Lilly Establishes up to $2.7B Repertoire Deal in Second Immune Play of 2026
The Repertoire partnership is Lilly’s second immunology play of the year, after the acquistion of Ventyx in early January for a pipeline of NLRP3 assets.
January 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Study Results of Novel TYK2 Inhibitor Soficitinib in Patients with AD Published by JAMA Dermatology
January 29, 2026
·
4 min read
Press Releases
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
January 29, 2026
·
3 min read
Press Releases
Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at Tandem
January 29, 2026
·
2 min read
Press Releases
Almirall Announces the Approval of Seysara® in China for the Treatment of Moderate-to-Severe Acne
January 29, 2026
·
8 min read
Press Releases
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
January 29, 2026
·
11 min read
Press Releases
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
January 29, 2026
·
4 min read
Press Releases
New Review Published in Immunotherapy Highlights the Potential for Clever-1 Inhibition with bexmarilimab to Become the Cornerstone of Next-Generation, Multi-Indication Cancer Immunotherapy
January 29, 2026
·
6 min read
Press Releases
Interim Results for the six months ended 31 October 2025
January 29, 2026
·
22 min read
Press Releases
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026
January 29, 2026
·
3 min read
1 of 87,003
Next
